Molecular docking simulations are computational methods that predict how small molecules, such as potential drug candidates, bind to target proteins by modeling their three-dimensional interactions and calculating binding affinities. Research published in In-vitro In-vivo In-silico Journal examines the integration o…
Molecular docking simulations are computational methods that predict how small molecules, such as potential drug candidates, bind to target proteins by modeling their three-dimensional interactions and calculating binding affinities. Research published in In-vitro In-vivo In-silico Journal examines the integration of these in silico techniques within the broader drug design pipeline, exploring how computational docking predictions complement experimental validation approaches. The journal's coverage addresses the progression from computational modeling through laboratory testing to biological evaluation, recognizing that docking simulations serve as an initial screening tool to identify promising molecular candidates before resource-intensive synthesis and testing. This computational approach matters because it can significantly reduce the time and cost associated with early-stage drug discovery by allowing researchers to evaluate thousands of potential compounds virtually, prioritizing only the most promising candidates for experimental investigation. By examining the interplay between computational predictions and experimental outcomes, the research contributes to understanding how docking simulations can be most effectively employed within integrated research strategies that combine computational, in vitro, and in vivo methodologies to advance therapeutic development.
1 peer-reviewed article, ranked by relevance. Each links to its DOI.